These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8769638)

  • 1. Disposition of zidovudine in obese pregnant women with human immunodeficiency virus type 1 infection.
    Acosta EP; Schwebke K; Henry K; Fletcher CV
    J Infect Dis; 1996 Sep; 174(3):673. PubMed ID: 8769638
    [No Abstract]   [Full Text] [Related]  

  • 2. Zidovudine pharmacokinetics during pregnancy.
    Sperling RS; Roboz J; Dische R; Silides D; Holzman I; Jew E
    Am J Perinatol; 1992 Jul; 9(4):247-9. PubMed ID: 1627212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic disposition of zidovudine during pregnancy.
    Watts DH; Brown ZA; Tartaglione T; Burchett SK; Opheim K; Coombs R; Corey L
    J Infect Dis; 1991 Feb; 163(2):226-32. PubMed ID: 1988507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further observations on zidovudine transfer and metabolism by human placenta.
    Liebes L; Mendoza S; Lee JD; Dancis J
    AIDS; 1993 Apr; 7(4):590-2. PubMed ID: 8507424
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.
    Rodman JH; Flynn PM; Robbins B; Jimenez E; Bardeguez AD; Rodriguez JF; Blanchard S; Fridland A
    J Infect Dis; 1999 Dec; 180(6):1844-50. PubMed ID: 10558940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
    Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
    Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center.
    Wiznia AA; Crane M; Lambert G; Sansary J; Harris A; Solomon L
    JAMA; 1996 May; 275(19):1504-6. PubMed ID: 8622226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation.
    Barzilai A; Sperling RS; Hyatt AC; Wedgwood JF; Reidenberg BE; Hodes DS
    Pediatr Infect Dis J; 1990 Dec; 9(12):931-3. PubMed ID: 2277754
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
    Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
    JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the use of zidovudine in pregnant women with HIV infection.
    De Santis M; Noia G; Caruso A; Mancuso S
    Drugs; 1995 Jul; 50(1):43-7. PubMed ID: 7588088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection.
    Sperling RS; Stratton P; O'Sullivan MJ; Boyer P; Watts DH; Lambert JS; Hammill H; Livingston EG; Gloeb DJ; Minkoff H
    N Engl J Med; 1992 Mar; 326(13):857-61. PubMed ID: 1542322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
    Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
    JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnant women with HIV infection: medical decision].
    Ciraru-Vigneron N
    Presse Med; 1996 May; 25(18):847-52. PubMed ID: 8692763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
    Panburana P; Sirinavin S; Phuapradit W; Vibhagool A; Chantratita W
    Am J Obstet Gynecol; 2004 Mar; 190(3):803-8. PubMed ID: 15042018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in Thailand.
    Briand N; Pornprasert S; Ngo-Giang-Huong N; Galactéros F; Pissard S; Tatu T; Sanguansermsri T; Jourdain G; Lallemant M; Le Coeur S
    Antivir Ther; 2009; 14(1):117-22. PubMed ID: 19320245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study.
    Kully C; Yerly S; Erb P; Kind C; Krautheim A; Perrin L; Rudin C
    J Infect Dis; 1999 Mar; 179(3):705-8. PubMed ID: 9952382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.